Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate vs propofol anesthesia in renal allograft transplantation
ChiCTR2200066634Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in chronic kidney disease (CKD) (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoints: Hemodynamics, Early postoperative recovery and 4 more. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR2200066634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066634.